All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 28 of 45
-
Class IIofficial
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL)Lack of Assurance of Sterility
-
Class IIofficial
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL)Lack of Assurance of Sterility
-
Class IIofficial
QuVa Pharma, Inc. recalls fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL)Lack of Assurance of Sterility
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
-
Class IIofficial
Golden State Medical Supply Inc. recalls PRASUGREL TABLETSFailed Dissolution Specifications
-
Class IIofficial
Strides Pharma, Inc. recalls Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.
-
Class IIofficial
Strides Pharma, Inc. recalls Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.
-
Class IIofficial
L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne TreatmentChemical Contamination: This recall has been initiated due to detected trace levels of benzene.
-
Class IIofficial
L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Dermatological Acne SystemcGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
-
Class IIofficial
L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne TreatmentcGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
-
Class IIofficial
Chattem Inc recalls UnisomCGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.
-
Class IIIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Tolterodine Tartrate Extended-Release CapsulesFailed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Gabapentin CapsulesCross Contamination
-
Class IIIofficial
Sun Pharmaceutical Industries Inc recalls Gabapentin CapsulesCross Contamination
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
-
Class IIofficial
Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
-
Class IIofficial
Sigan Industries Group Inc. recalls WalgreensChemical Contamination: Presence of benzene
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC 68462-162-01)CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 6.25 mgCGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 12.5 mgCGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 25 mgCGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
-
Class IIofficial
Amgen, Inc. recalls Neupogen (filgrastim) For InjectionStability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
-
Class IIofficial
Amgen, Inc. recalls Neupogen (filgrastim) For InjectionStability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
-
Class IIofficial
Mylan Pharmaceuticals Inc recalls Prasugrel TabletsFailed Dissolution Specifications - low dissolution results
-
Class IIofficial
A-S Medication Solutions LLC recalls METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MGPresence of Foreign Tablets/Capsules.
-
Class IIIofficial
Kowa Pharmaceuticals America recalls Livalo (pitavatstatin) tabletsPresence of foreign tablets/capsules
-
Class IIofficial
Denison Pharmaceuticals, LLC recalls ZapzytChemical Contamination: Presence of benzene.
-
Class IIIofficial
Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic SolutionSub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
-
Class Iofficial
Central Admixture Pharmacy Services, Inc. recalls PHENYLephrine added to 0.9% sodium chloridePresence of Particulate Matter
-
Class Iofficial
One Source Nutrition, Inc, recalls VitalityMarketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.
-
Class IIofficial
Turbare Manufacturing recalls Avastin 1.25 mg/0.05 mL in 0.25 mL SyringeLack of Assurance of Sterility: due to a quality control process deviation
-
Class IIofficial
Safecor Health, LLC recalls Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral SyringeDefective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
-
Class IIofficial
Safecor Health, LLC recalls Simethicone 20 mg per 0.3 mL Oral SyringeDefective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
-
Class IIofficial
Safecor Health, LLC recalls Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral SyringeDefective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
-
Class IIofficial
Safecor Health, LLC recalls Lorazepam 0.5 mg per 0.25 mL Oral SyringeDefective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
-
Class IIofficial
Safecor Health, LLC recalls Morphine Sulfate 5 mg per 0.25 mL Oral SyringeDefective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls Medline Alcohol Prep PadsSubpotent Drug
-
Class IIofficial
MEDLINE INDUSTRIES, LP - Northfield recalls CURAD Alcohol Prep PadsSubpotent Drug
-
Class Iofficial
CareFusion 213, LLC recalls BD ChloraPrep Clear 1mL ApplicatorsNon-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFailed Impurities/Degradation Specifications
-
Class IIofficial
Zydus Pharmaceuticals (USA) Inc recalls Nelarabine InjectionFailed Impurities/Degradation Specifications
-
Class Iofficial
ICU Medical, Inc. recalls POTASSIUM CHLORIDE Inj.Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling affixed to the product flexible container.
-
Class Iofficial
ICU Medical, Inc. recalls POTASSIUM CHLORIDE Inj.Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq
-
Class IIofficial
Johnson, S C and Son, Inc recalls Kids by babyganics SPF 50 totally tropical (titanium dioxide 3/5%Chemical Contamination
-
Class IIofficial
Johnson, S C and Son, Inc recalls Kids by babyganics SPF 50 mineral sunscreen totally tropical (titanium dioxide 3/5%Chemical Contamination
-
Class IIofficial
World Perfumes Inc. recalls Iodo Blanco IodidesDefective Container: broken or leaking bottles.
-
Class IIofficial
Wuxi Medical lnstrument Factory Co., Ltd. recalls ViaMed Alcohol Prep PadsLack of assurance of sterility and cGMP deviations observed at the manufacturing site.
-
Class IIofficial
Nephron Sterile Compounding Center LLC recalls Sodium Chloride Injection 9%Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
-
Class IIofficial
Aspen Biopharma Labs Pvt., Ltd. recalls Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finallyCGMP Deviations